Inhaltsstoffe: Myo-Inositol, Reismehl, N-Acetyl-L-Carnitinhydrochlorid, berzugsmittel: Hydroxypropylmethylcellulose (pflanzliche Kapselhlle), Eisensulfat, Zinkbisglycinat, Mnchspfefferfrucht-Extrakt (Vitex agnus castus), Pyridoxinhydrochlorid, Calcium-L-Methylfolat, Methylcobalamin
Circular RNA circ-LDLRAD3 serves as an oncogene to promote non-small cell lung cancer progression by upregulating SLC1A5 through sponging miR-137
Safety and risks : Unknown long-term effects, potential cancer concerns via angiogenesis
Clinical Evidence and Current Research Status Published evidence for glutathione IV therapy varies by indication
However, greater insight into the relationship between oxidative stress and disease susceptibility may be gained by studying functional polymorphisms in genes that control levels of cellular oxidative damage